• 5. Sanofi spin-off: bidding war over the future of Pharma

  • Oct 14 2024
  • Length: 31 mins
  • Podcast

5. Sanofi spin-off: bidding war over the future of Pharma

Listen for free

View show details

  • Summary

  • In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 5. Sanofi spin-off: bidding war over the future of Pharma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available